THMO Bounces

Hello,

Yes, what you are seeing is real from ATH to ATL. This could be a bargain but only if ThermoGenisis Holdings pulls a rabbit out of the hat. Apparently news of late may just be that. Read some of the highlights below then decide for yourself.

First Quarter and Subsequent Achievements:
*Net revenues for the first quarter of 2020 increased to $3.2 million, up 8% compared to the same period in 2019.

*Gross profit for the first quarter was $1.5 million, an increase of 19% compared to the same period in 2019.

*On March 31, the Company submitted notification to the U.S. Food and Drug Administration (FDA) of its intention to register and market the ThermoGenesis' SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit in accordance with Section IV. D. of the "Policy for Diagnostic Tests for Coronavirus Disease – 2019 during the Public Health Emergency," issued by FDA on March 16, 2020. ("Policy D").

*On April 15, the Company received an acknowledgment letter from the FDA, confirming that ThermoGenesis' SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit has been appropriately validated for distribution under the Policy D guideline.

*The Company's joint venture, ImmuneCyte Life Sciences, Inc. (ImmuneCyte), acquired the worldwide intellectual property for the development of fully human antibody therapeutics for COVID-19, including four high-affinity monoclonal antibody drug candidates against SARS-CoV-2 and tools for screening and quantifying efficacy of such neutralizing antibodies.

Full Article

Good Luck
Cheers!

Be sure to follow, like, and check my profile out for more trade ideas!